Dianthus Therapeutics Inc (DNTH)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Jason Gardner |
| Employees: | 80 |
| Web site: | magentatx.com |
|
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
929-999-4055
| |
| Date | Ratio |
|---|---|
| 2023-09-12 | 1:16 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Magenta Therapeutics develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy.
Please log in first to see chart